Nachrichten zur Pfizer Aktie

Pfizer: FDA Grants Priority Review For BLA For Elranatamab

NEW YORK CITY (dpa-AFX) - Pfizer Inc. (PFE) announced the FDA has granted Priority Review for the companys Biologics License…

Pfizer Gets FDA Priority Review for Elranatamab in Multiple Myeloma >PFE

Pfizer Gets FDA Priority Review for Elranatamab in Multiple Myeloma >PFE...…

Pfizer, GSK Are Competing to Make the Best RSV Vaccine

Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...…

Pfizer: Zulassungsantrag für den RSV-Impfstoffkandidaten akzeptiert - Aktienanalyse

Kulmbach (www.aktiencheck.de) - Pfizer-Aktienanalyse von "Der Aktionär": Marion Schlegel vom Anlegermagazin "Der Aktionär" nimmt die Aktie von Pfizer Inc. (ISIN: US7170811035,…

BioNTech-Partner Pfizer: RSV-Impfstoff auf der Zielgeraden – Termin vormerken

Pfizer kommt bei seinem RSV-Impfstoffkandidaten RSVpreF (PF-06928316) voran. Wie der US-Pharmakonzern mitgeteilt hat, hat die amerikanische Zulassungsbehörde FDA den Zulassungsantrag…

Pfizer looks set to be the first deliver a long-awaited RSV drug

Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...…

Pfizer RSV vaccine that protects infants could receive FDA approval this summer

The single-dose RSV vaccine developed by Pfizer is administered to expectant mothers in the late second-to-third trimester of their pregnancy....…

Lung Cancer Drugs Global Market Report 2023

NEW YORK, Feb. 21, 2023 /PRNewswire/ -- Major players in the lung cancer market are Bristol-Myers Squibb Company, Merck &…

First RSV Vaccine For Kids—Given To Pregnant Moms—Could Arrive Months Early As FDA Fast-Tracks Review

If approved, Pfizers RSV shot for pregnant people could be the first on the market and protect infants from complications…

Pfizer: FDA Accepts For Review BLA For Respiratory Syncytial Virus Vaccine Candidate

NEW YORK CITY (dpa-AFX) - Pfizer Inc. (PFE) announced the FDA has accepted for review a Biologics License Application for…

Pfizer Gets FDA Priority Review of Respiratory Syncytial Virus Maternal Vaccine Candidate >PFE

Pfizer Gets FDA Priority Review of Respiratory Syncytial Virus Maternal Vaccine Candidate >PFE...…

Pfizer Knowingly Allowed Dangerous Components In Its Vaccines

Pfizer Knowingly Allowed Dangerous Components In Its Vaccines Authored…

Antacids Global Market Report 2023

NEW YORK, Feb. 20, 2023 /PRNewswire/ -- Major players in the antacids market are GlaxoSmithKline plc, Pfizer Inc., Bayer AG,…

Antiglaucoma Drugs Global Market Report 2023

NEW YORK, Feb. 20, 2023 /PRNewswire/ -- Major players in the antiglaucoma drugs market are Aerie Pharmaceuticals, Inc., Allergan, Novartis…

Pfizer Inc. (PFE) is Attracting Investor Attention: Here is What You Should Know

Pfizer (PFE) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what…

Bladder Cancer Drugs Global Market Report 2023

NEW YORK, Feb. 17, 2023 /PRNewswire/ --Major players in the bladder cancer drugs market are Pfizer, Celgene Corporation, Eli Lilly,…

Pfizer Shuts Trial Sites for Lyme Disease Jab After Standards Breaches

The company and its partner Valneva have removed about half of the participants from the Vaccine program, citing violations of…

UPDATE 2-Pfizer, Valneva to stop testing Lyme disease vaccine in some U.S. patients

... (Reuters) - Drugmaker Pfizer Inc and Frances Valneva will stop testing......…

Pfizer, Valneva removes ~50% participants in Lyme disease vaccine trial on violation woes

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Null-Toleranz? Europaparlament im Korruptionssumpf

EU-Parlamentspräsidentin will offiziell mehr Transparenz. Das gilt aber offenbar nicht für die Pfizer-SMS von der Leyens oder Metsolas Angaben zu…

Valneva, Pfizer to Discontinue Some Trials for Lyme Disease Vaccine

Valneva, Pfizer to Discontinue Some Trials for Lyme Disease Vaccine...…

Pfizer and Valneva discontinue some trials on vaccine against Lyme disease

...PARIS (Reuters) - U.S. drugs giant Pfizer and vaccine company......…

Pfizer and Valneva Issue Update on Phase 3 Clinical Trial Evaluating Lyme Disease Vaccine Candidate VLA15

New York & Saint-Herblain (France), February 17, 2023 – Pfizer Inc. (NYSE: PFE) and Valneva SE (Nasdaq: VALN; Euronext Paris:…

Klage gegen EU-Kommission: Was steht in den SMS von der Leyens an Pfizer?

New York Times versucht über ein EU-Gericht herauszufinden, wie die "persönliche Diplomatie" zwischen der EU-Kommissionspräsidentin und dem Chef des US-Pharmakonzerns…

Antiobesity Global Market Report 2023

NEW YORK, Feb. 16, 2023 /PRNewswire/ -- Major players in the anti-obesity market are F. Hoffmann-La Roche AG, GlaxoSmithKline PLC,…

Pfizer/ BioNTech, Moderna set for 2024 trial in COVID vaccine patent dispute

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Pfizer Reports Positive Data From Phase 3 Trial Of Talzenna/Xtandi Combo

NEW YORK CITY (dpa-AFX) - Pfizer (PFE) Thursday reported positive results from the Phase 3 TALAPRO-2 study of Talzenna, an…

Drug makers are looking to drive diversity in clinical trials

Bertha Coombs reports drug makers are trying to up the ante on diversity in clinical trials. Eli Lilly's mobile lab…

Protein Inhibitors Global Market Report 2023

NEW YORK, Feb. 16, 2023 /PRNewswire/ -- Major players in the protein inhibitors market are Bayer AG, Astra Zeneca, Roche,…

Cervical Cancer Drugs Global Market Report 2023

NEW YORK, Feb. 16, 2023 /PRNewswire/ -- Major players in the cervical cancer drugs market are F. Hoffmann-La Roche Ltd,…

Pfizer granted priority review for Talzenna, Xtandi combination for prostate cancer

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Pfizer Reports Positive Data, Priority Review for Talzenna/Xtandi Combo >PFE

Pfizer Reports Positive Data, Priority Review for Talzenna/Xtandi Combo >PFE...…

Global Artificial Intelligence in Cancer Diagnostics Market Report 2022 to 2030: Players Include Pfizer, Therapixel, Sophia Genetics and Freenome

DUBLIN, Feb. 14, 2023 /PRNewswire/ -- The "Artificial Intelligence in Cancer Diagnostics Market Share, Size, Trends, Industry Analysis Report, By…

New York Times verklagt EU-Kommission wegen von der Leyens Pfizer-SMS

In dem Streit geht um die Kommunikation zwischen Ursula von der Leyen und Pfizer-Chef Albert Bourla zu milliardenschweren Lieferungen von…

Rituximab Biosimilars Global Market Report 2023

NEW YORK, Feb. 13, 2023 /PRNewswire/ -- Major players in the rituximab biosimilars market are Pfizer Inc., Mylan Inc., Amgen…

DTP Vaccines Global Market Report 2023

NEW YORK, Feb. 13, 2023 /PRNewswire/ -- Major players in the DTP vaccines market are Merck & Co, Sanofi, GSK,…

Vascular Endothelial Growth Factor (VEGF) Inhibitor Global Market Report 2023

NEW YORK, Feb. 13, 2023 /PRNewswire/ -- Major players in the vascular endothelial growth factor (VEGF) inhibitor market are Pfizer,…

Monoclonal Antibodies (MAbS) Global Market Report 2023

NEW YORK, Feb. 13, 2023 /PRNewswire/ -- Major players in the monoclonal antibodies (MABS) market are Johnson & Johnson, Merck,…

Pfizer (PFE) Eczema Drug Cibinqo Gets FDA Nod for Adolescents

The FDA approval for Pfizers (PFE) Cibinqo to treat moderate-to-severe atopic dermatitis in adolescents was based on data from the…

Exxon Is an Exile on Wall Street and Loving It

The Dow Jones Industrial Averages shake-up in the summer of 2020 dumped Exxon Mobil, Pfizer and Raytheon just as it…

BioNTech: Eine neue Studie mit dem US-Partner Pfizer gestartet - Aktienanalyse

Kulmbach (www.aktiencheck.de) - BioNTech-Aktienanalyse von "Der Aktionär": Marion Schlegel vom Anlegermagazin "Der Aktionär" nimmt die Aktie von BioNTech SE (ISIN: US09075V1026,…

BioNTech gibt Gas bei Pipelineprojekten – neue Studie

BioNTech und der US-Partner Pfizer haben eine neue Studie gestartet. Untersucht wird die Sicherheit, Verträglichkeit und Immunogenität ihrer mRNA-Impfstoffkandidaten gegen…

Global Immunotherapy Drugs Market Report to 2028 - Players Include F. Hoffmann-La Roche, GSK, Merck & Co, Pfizer and Sanofi

DUBLIN, Feb. 11, 2023 /PRNewswire/ -- The "Immunotherapy Drugs Market by Type, Therapy Area, End User, and Region 2023-2028" report…

Global Biosimilars Market Report to 2027: Featuring Novartis, Pfizer, Amgen, LG Life Sciences and Synthon Pharmaceuticals Among Others

DUBLIN, Feb. 10, 2023 /PRNewswire/ -- The "Global Biosimilars Market Size, Trends and Growth Opportunity, By Product, By Indication, By…

Global Oral Thin Film Drugs Market Report 2022-2030 Featuring Monosol Rx, Tesa Labtec, Pfizer, Novartis, Wolters Kluwer, Solvay, Allergan, Sumitomo Dainippon Pharma, Intelgenx, Transition Therapeutics

DUBLIN, Feb. 10, 2023 /PRNewswire/ -- The "Oral Thin Film Drugs Market Size, Market Share, Application Analysis, Regional Outlook, Growth…

dpa-AFX ProFeed